Odd

Jump to

USFDA grants ODD status to Zydus Lifesciences medicine to treat CAPS

The grant of Orphan Drug Designation (ODD) by the US Food and Drug Administration (USFDA) for ZYIL1 provides eligibility for certain development incentives, including tax credits for qualified clinical testing, prescription drug user fee exemptions and seven-year marketing exclusivity upon FDA approval, the company said in a regulatory filing.
Delhi governments's odd-even formula kicks off today

The Delhi government's big experiment to get private cars off the roads to check pollution levels in the national capital kicks off on Friday.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Odd

USFDA grants ODD status to Zydus Lifesciences medicine to treat CAPS

Delhi governments's odd-even formula kicks off today